findmyKOL

Leslie Jones, MD

Basic profile

Howard University

ORCIDNPI
RegionWashington, DC · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH funding2007–2008

Leslie Jones is an Ophthalmology physician affiliated with Howard University. OpenAlex indexes 51 publications with 955 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
51publications

Distinct works indexed by OpenAlex, matched via ORCID.

955citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
26companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2007–2008

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2041 Georgia Ave NW
Washington, DC 200600001

Telephone

202-865-1257

Registry record last updated 22 Aug 2007.

View the NPPES registry record

Industry payments

26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    85.2%
    Prostaglandin Analog29.2%
    Latanoprost86%Travoprost8%Lumigan7%
    Part D<11 patients
    Carbonic Anhydrase Inhibitor27.6%
    Dorzolamide-Timolol58%Simbrinza18%Brinzolamide12%Acetazolamide Er7%Dorzolamide Hcl5%
    Part D<11 patients

    + 4 more classes in this area

  • Cancer & immunology

    8.1%
    Calcineurin inhibitor8.1%
    Restasis43%Restasis Multidose43%Cyclosporine14%
    Part D<11 patients
  • Cardiovascular

    5.2%
    Beta blocker5.2%
    Timolol Maleate100%
    Part D18 patients
Where care is delivered (Part B)4.9% facility · 95.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20072008 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”